CatalYm
GermanyCatalYm is a biotech company, headquartered in Germany.
Entry
2022
Hold
4yr
Status
Active
Est. EV
–
Key facts
HQGermany
SectorBiotech
StatusActive
Munich-based clinical-stage immuno-oncology biotech developing visugromab (anti-GDF-15) for solid tumors; Jeito Capital backed in 2022 and…Read full notes
See the full ownership history.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Full fund context: vintage, strategy, region
Already a member? Sign in
More from Jeito I
Other portfolio companies in the same fund.
France
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Last updated May 2026 · Sourced from public filings
Spain
US
Denmark
UK